Guardian Science Weekly

Are we finally nearing a treatment for Alzheimer’s?

--:--
Back in November, researchers hailed the dawn of a new era of Alzheimer’s therapies. After decades of failure, a clinical trial finally confirmed that a drug, lecanemab, was able to slow cognitive decline in patients with early stages of the disease. The result may have been modest – a reduction in the decline in patients’ overall mental skills by 27% over 18 months – but it could not be more significant in the journey towards better understanding and treating the disease. Ian Sample speaks to Prof Nick Fox about the clinical trial results, if this could be the first of many new Alzheimer’s therapies, and whether we could one day see a cure.. Help support our independent journalism at theguardian.com/sciencepod
29 Dec 2022 English United Kingdom Science · Nature

Other recent episodes

Could faecal transplants be the next frontier in health?

Madeleine Finlay hears from science correspondent Linda Geddes about her experience becoming a faecal transplant donor, how getting a dose of someone else’s gut bacteria could treat illnesses like arthritis, diabetes and cancer, and asks whether a pill made from poo is an idea we are ready to swallow. Help…
28 Mar 16 min

Three years on: are we any closer to understanding long Covid?

Ian Sample hears from Scotland’s Astronomer Royal Catherine Heymans about her experience of long Covid and how it has impacted her life. He also speaks to Professor Danny Altmann, an immunologist at Imperial College London, about the current scientific understanding of the condition, and whether we’re any closer to a…
23 Mar 17 min

Willow Project: what could the ‘carbon bomb’ mean for the environment?

Madeleine Finlay speaks to Guardian West Coast reporter Maanvi Singh about the Biden administration’s approval of a controversial new oil drilling project on Alaska’s North Slope. She also hears from Kristen Monsell, a senior attorney at the Center for Biological Diversity, which is part of a coalition that’s filing a…
21 Mar 16 min

How will gene editing change medicine and who will benefit?

Ian Sample speaks to Guardian science correspondent Hannah Devlin about the latest developments and debates about gene editing to emerge from a summit at the Francis Crick Institute in London. The summit heard from the first person with sickle cell disease to be treated with a technique known as Crispr…
16 Mar 16 min
All episodes